Table of Contents
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter's Fiver Forces Analysis 36
3 Segmentation of Europe Market by Category 41
3.1 Market Overview by Category 41
3.2 Pharmaceutical Industry 43
3.3 Biopharmaceutical Industry 44
4 Segmentation of Europe Market by Product 45
4.1 Market Overview by Product 45
4.2 Active Pharmaceutical Ingredients (API) 47
4.2.1 Branded API Manufacturing 48
4.2.2 Generic API Manufacturing 49
4.3 Finished Dosage Formulations (FDF) 50
4.3.1 Solid Dosage 52
4.3.2 Oral Liquids 53
4.3.3 Parenteral/Injectables 54
4.3.4 Other FDFs 55
4.4 Secondary Packaging 56
5 Segmentation of Europe Market by Phase 57
5.1 Market Overview by Phase 57
5.2 Clinical Manufacturing 59
5.3 Commercial Manufacturing 60
6 Segmentation of Europe Market by Type 61
6.1 Market Overview by Type 61
6.2 Sterile Products 63
6.3 Non-Sterile Products 64
7 Segmentation of Europe Market by Therapeutic Application 65
7.1 Market Overview by Therapeutic Application 65
7.2 Infectious Diseases 67
7.3 Oncology 68
7.4 Metabolic Disorders 69
7.5 Cardiovascular Disorders 70
7.6 Central Nervous System 71
7.7 Pulmonary Disorders 72
7.8 Gastrointestinal Disorders 73
7.9 Other Therapeutic Applications 74
8 European Market 2019-2030 by Country 75
8.1 Overview of European Market 75
8.2 Germany 78
8.3 UK 80
8.4 France 82
8.5 Spain 84
8.6 Italy 86
8.7 Russia 88
8.8 Rest of European Market 90
9 Competitive Landscape 92
9.1 Overview of Key Vendors 92
9.2 New Product Launch, Partnership, Investment, and M&A 96
9.3 Company Profiles 97
Aenova Group 97
Baxter BioPharma Solutions 99
Boehringer Ingelheim 100
Catalent Inc. 101
Famar S.A. 102
Hospira, Inc. 103
Jubilant Life Sciences Ltd. 104
Lonza Group 105
Patheon Inc. 106
Pfizer CentreSource 107
Recipharm AB 108
Vetter Pharma International GmbH 109
10 Investing in Europe Market: Risk Assessment and Management 110
10.1 Risk Evaluation of Europe Market 110
10.2 Critical Success Factors (CSFs) 113
Related Reports and Products 116